Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: May 6, 2009


El Camino Hospital has appointed Paul Billings as acting director and chief science officer of its new Genomic Medicine Institute. Billings is co-founder of GeneSage; co-founder and first medical director of CBR Systems; and advisor for CELLective Dx Corporation. He was previously VP of corporate development and senior geneticist at the Laboratory Corporation of America and an adjunct professor in the department of anthropology at University of California, Berkeley.

DxS appointed Chief Operating Officer Jeff Devlin to its executive board. Before joining DxS this January, Devlin was executive VP of Shire Pharmaceuticals and a partner at Ernst & Young's life sciences division.

Additionally, Peter Collins has been appointed senior VP of business development at DxS. Previously, Collins has held senior executive roles at Vysis, a subsidiary of Abbott Molecular Diagnostics; Quantase, a subsidiary of Bio-Rad Laboratories; as well as Gentronix, Biogenex, and Pronostics.

Filed under

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.